SCHEMBL6417535

SCHEMBL6417535

CC(=O)c1c2nc(cc3ccc(cc4nc(cc5[nH]c1c1ccccc51)C=C4)[nH]3)C=C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 3/20 0.39
▸ STAT1 P42224 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ TP53 P04637 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ BCHE P06276 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ PARP14 Q460N5 2/20 0.33
▸ MPL P40238 2/20 0.32
▸ GABRP O00591 1/20 0.32
▸ GABRD O14764 1/20 0.32
▸ GABRA1 P14867 1/20 0.32
▸ GABRB1 P18505 1/20 0.32
▸ GABRG2 P18507 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13504831 0.89 STAT3 (0.42) STAT3STAT1KDM4EMAPTTP53
SCHEMBL9095058 0.87 STAT3 (0.45) STAT3STAT1KDM4EMAPTTP53
SCHEMBL351897 0.81 STAT3 (0.45) STAT3STAT1MAPTHSD17B10BRD4
SCHEMBL1597373 0.79 STAT3 (0.43) STAT3STAT1MAPTHSD17B10BRD4
SCHEMBL2825510 0.79 STAT3 (0.43) STAT3STAT1KDM4EMAPTHSD17B10
SCHEMBL1596068 0.78 STAT3 (0.47) STAT3STAT1KDM4EMAPTHSD17B10
SCHEMBL351526 0.77 STAT3 (0.43) STAT3STAT1MAPTHSD17B10BRD4
SCHEMBL2774805 0.77 CYCS (0.49) STAT3STAT1KDM4EALDH1A1HPGD
SCHEMBL351525 0.76 BRD4 (0.35) STAT3STAT1KDM4EMAPTHSD17B10
SCHEMBL27307 0.76 AHR (0.47) STAT3STAT1KDM4EMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1450790-A4 PHOTOSENSITIZING CARBAMATE DERIVATIVES MIRAVANT PHARM INC (US) 2005-10-26 — — EP disclosed
US-20040266748-A1 Photosensitizing carbamate derivatives MIRAVANT PHARMACEUTICALS, INC. 2004-12-30 — — US disclosed
EP-1450790-A2 PHOTOSENSITIZING CARBAMATE DERIVATIVES Miravant Pharmaceuticals, Inc. (US) 2004-09-01 — — EP disclosed
WO-2003028628-A2 PHOTOSENSITIZING CARBAMATE DERIVATIVES MIRAVANT PHARMACEUTICALS, INC. (US) 2003-04-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266748-A1 Photosensitizing carbamate derivatives CRY1, CASP3, CRY2 STAT3 3053/4885STAT1 2564/4885KDM4E 238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback